Insights · Pharmaceutical Strategy
Everything on Pharmaceutical Strategy
2 insights · 2 episodes
-
Patent expirations in emerging markets are democratizing access to blockbuster drugs while rewarding manufacturers with superior cold-chain infrastructure. Generic producers with proven quality control will capture Western market share as patents expire globally.
Impact: Generic producers with proven quality control will capture Western market share as patents expire globally.
— from AI Financing Shifts, Rhine Logistics Crisis, and Pharma Patent Dynamics · Alles auf Aktien – Die täglichen Finanzen-News· Aug 11, 2026
-
Novartis faces substantial revenue declines due to US patent expirations, with key drug sales dropping 40-65% as generics enter the market.
Impact: Underscores the critical need for robust pipeline development and strategic acquisitions to offset patent cliff impacts.
— from Market Shifts: AI Costs, Pricing Strategies, and Sector Realignment · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Apr 29, 2026